Skip to main content

Peer Review reports

From: A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

Original Submission
2 Aug 2016 Submitted Original manuscript
3 Oct 2016 Reviewed Reviewer Report - John McAuliffe
19 Oct 2016 Reviewed Reviewer Report - Motoyoshi Tanaka
17 Nov 2016 Author responded Author comments - Berta Laquente
Resubmission - Version 2
17 Nov 2016 Submitted Manuscript version 2
15 Dec 2016 Author responded Author comments - Berta Laquente
Resubmission - Version 3
15 Dec 2016 Submitted Manuscript version 3
20 Jan 2017 Author responded Author comments - Berta Laquente
Resubmission - Version 4
20 Jan 2017 Submitted Manuscript version 4
6 Feb 2017 Author responded Author comments - Berta Laquente
Resubmission - Version 5
6 Feb 2017 Submitted Manuscript version 5
Publishing
9 Feb 2017 Editorially accepted
15 Feb 2017 Article published 10.1186/s12885-017-3131-x

You can find further information about peer review here.

Back to article page